Indemnification is a contractual commitment to legally and financially protect the investigator or trial site against claims arising from a clinical trial. Under ICH E6(R3), it covers claims arising from the trial, but not claims resulting from malpractice or negligence. <\/p>\n
Indemnification is often set out in the contract between the sponsor and the investigator or institution. It specifies under which conditions the sponsor will defend against claims or bear costs asserted against the trial site or investigator in connection with the trial. ICH E6(R3) uses the term \u201cindemnify\u201d and describes it as legal and financial coverage. Whether indemnification is required, and in what form, depends on the applicable regulatory requirements and the relevant contract law. <\/p>\n
A properly drafted clause must therefore clearly define the trial-related scope covered, possible procedural steps, notification obligations, and exceptions. It must not obscure responsibility for one\u2019s own misconduct. The ICH exception for claims arising from malpractice and negligence makes clear that indemnification is not intended to broadly shift malpractice or negligent conduct by the investigator or institution to the sponsor. The specific legal effect depends on the national legal system and the contract. <\/p>\n
ICH E6(R3) addresses insurance, indemnification, and compensation in a single section, but they are different mechanisms. Insurance is an insurance arrangement that covers a defined scope of loss. Indemnification is a commitment between the contracting parties to protect the indemnified investigator or institution economically and legally against certain claims. It may be supported by insurance, but it is not identical to the insurance contract. <\/p>\n
Compensation for participants, in turn, concerns treatment costs and, where applicable, compensation for trial-related harm. Regulation (EU) No 536\/2014 requires a system for the payment of compensation for harm suffered by participants under the law of the Member State concerned. This legally required compensation regime protects the participating person. Indemnification, by contrast, allocates risks between the sponsor, CRO, and trial site; it replaces neither participant insurance nor the national compensation regime. <\/p>\n
Indemnification does not change who is regulatorily responsible for the trial. The sponsor may delegate tasks to service providers, but remains ultimately responsible for its sponsor obligations. The investigator remains responsible for their medical and trial-related duties. Contractual indemnification and regulatory obligations therefore do not fully align. The Commission Q&A also emphasises that civil and criminal liability is not conclusively governed by the Regulation itself, but is assessed under national law. <\/p>\n
Indemnification may also be agreed between the sponsor and the CRO, for example for claims arising from an assumed service. However, it must be distinguished from the task delegation agreement: the latter governs performance, quality requirements, and oversight; indemnification governs the allocation of risk for claims. In trial site agreements, both topics often appear side by side, but they should not be conflated in substance. <\/p>\n
Particular care is required when multiple contracts interact, for example between the sponsor, CRO, hospital, and individual investigators. Different terms for damage, claim, defence costs, or contributory negligence can lead to inconsistent provisions. While the operational trial file should document the contract status and the required evidence, it should not pre-empt the interpretation of complex legal issues. Where necessary, these require review under the applicable national law. <\/p>\n
During contract negotiations, investigators and institutions need clarity on which claims are covered, how an incident is reported, and which exceptions apply. Unclear clauses can delay site initiation and, in the event of an incident, lead to disputes over legal defence, costs, or communication. In parallel, the required insurance evidence, provisions on treatment costs, and information for participants must align with the respective study and national law. <\/p>\n
Full-service CROs such as Mediconomics support the coordination of trial site agreements, the collection and filing of required insurance evidence, and the alignment of responsibilities between the sponsor, trial site, and service providers. They can manage contract status, documentation for ethics committees, safety communications, and Trial Master File documentation from a project management perspective, without replacing the legal review by the responsible specialist functions. <\/p>\n
Is indemnification the same as participant insurance?<\/strong><\/p>\n No. Indemnification concerns the relationship between contracting parties. Coverage and compensation for participants in the event of trial-related harm follow separate statutory and insurance-law requirements. <\/p>\n Does indemnification cover the investigator\u2019s malpractice?<\/strong><\/p>\n Under ICH E6(R3), claims arising from malpractice or negligence are excluded from the indemnification described there. The specific contract and national law are decisive. <\/p>\n Does Regulation (EU) No 536\/2014 govern all civil liability?<\/strong><\/p>\n No. It requires a system for compensating harm suffered by participants, but otherwise leaves civil and criminal liability issues to the law of the Member States. <\/p>\n Indemnification is a contractual commitment to legally and financially protect the investigator or trial site against claims arising from a clinical trial. Under ICH E6(R3), it covers claims arising from the trial, but not claims resulting from malpractice or negligence. Content and contractual function Indemnification is often set out in the contract between the sponsor […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[21],"class_list":["post-7810","glossary","type-glossary","status-publish","hentry","glossary-cat-clinical-operations-gcp"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":0,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/7810\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=7810"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=7810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Regulatory References<\/h2>\n
\n